These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6144180)

  • 1. Repeated pentagastrin-stimulated gastric acid secretory tests carried out in the evaluation of the pharmacodynamics of a new histamine H2-receptor antagonist, SK&F 93479.
    Jönsson KA; Bodemar G; Norlander B; Walan A
    Scand J Gastroenterol; 1984 Mar; 19(2):209-15. PubMed ID: 6144180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mifentidine, a new H2-antagonist, on pentagastrin-stimulated acid secretion in healthy subjects.
    Lazzaroni M; Ardizzone S; Imbimbo BP; Sangaletti O; Ghirardosi C; Bianchi Porro G
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):218-21. PubMed ID: 2884190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
    Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
    Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical analysis of the gastric secretory response of patients with duodenal ulcer in dependence of their age and duration of complaints.
    Mózsik G; Venter E; Schmelczer M; Kutas J; Nagy L; Tárnok F
    Acta Med Acad Sci Hung; 1981; 38(2):117-28. PubMed ID: 7324803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J; Kunert H; Ottenjann R
    Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine.
    Richardson CT; Feldman M; Brater C; Welborn J
    Gastroenterology; 1981 Feb; 80(2):301-6. PubMed ID: 6108895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man.
    Nwokolo CU; Sawyerr A; Smith JT; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():75-83. PubMed ID: 1983349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.
    Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W
    Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and gastric secretory studies of ranitidine in man.
    Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
    Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
    Fukuda Y; Ikezoe I; Okabayashi M; Ohama I; Shimoyama T
    Clin Ther; 1987; 9(5):528-35. PubMed ID: 2889528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
    Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
    Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
    Campbell CA; Gaskin PJ; Darton J; Chiu P; Lee K; McLean PG
    Eur J Pharmacol; 2008 Jul; 589(1-3):260-3. PubMed ID: 18571645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
    Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
    J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of nocturnal acid secretion. Test of the new histamine H2 receptor antagonist SKF 93479: effect over 12 hours].
    Dammann HG; Müller P; Simon B
    MMW Munch Med Wochenschr; 1982 Feb; 124(5):103-4. PubMed ID: 6123944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.